Agilent Technologies Comprehensive Income 2010-2025 | A
Agilent Technologies comprehensive income from 2010 to 2025. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Agilent Technologies comprehensive income for the quarter ending April 30, 2025 was $-0.280B, a 16.91% decline year-over-year.
- Agilent Technologies comprehensive income for 2024 was $-0.305B, a 6.73% decline from 2023.
- Agilent Technologies comprehensive income for 2023 was $-0.327B, a 5.76% decline from 2022.
- Agilent Technologies comprehensive income for 2022 was $-0.347B, a 23.05% increase from 2021.
| Agilent Technologies Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024 | $-305 |
| 2023 | $-327 |
| 2022 | $-347 |
| 2021 | $-282 |
| 2020 | $-522 |
| 2019 | $-514 |
| 2018 | $-408 |
| 2017 | $-346 |
| 2016 | $-503 |
| 2015 | $-391 |
| 2014 | $-334 |
| 2013 | $91 |
| 2012 | $-111 |
| 2011 | $116 |
| 2010 | $-88 |
| 2009 | $-185 |
| Agilent Technologies Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2025-04-30 | $-280 |
| 2025-01-31 | $-381 |
| 2024-10-31 | $-305 |
| 2024-07-31 | $-331 |
| 2024-04-30 | $-337 |
| 2024-01-31 | $-316 |
| 2023-10-31 | $-327 |
| 2023-07-31 | $-271 |
| 2023-04-30 | $-282 |
| 2023-01-31 | $-280 |
| 2022-10-31 | $-347 |
| 2022-07-31 | $-362 |
| 2022-04-30 | $-333 |
| 2022-01-31 | $-298 |
| 2021-10-31 | $-282 |
| 2021-07-31 | $-454 |
| 2021-04-30 | $-452 |
| 2021-01-31 | $-469 |
| 2020-10-31 | $-522 |
| 2020-07-31 | $-476 |
| 2020-04-30 | $-538 |
| 2020-01-31 | $-521 |
| 2019-10-31 | $-514 |
| 2019-07-31 | $-404 |
| 2019-04-30 | $-398 |
| 2019-01-31 | $-381 |
| 2018-10-31 | $-408 |
| 2018-07-31 | $-335 |
| 2018-04-30 | $-310 |
| 2018-01-31 | $-269 |
| 2017-10-31 | $-346 |
| 2017-07-31 | $-417 |
| 2017-04-30 | $-477 |
| 2017-01-31 | $-489 |
| 2016-10-31 | $-503 |
| 2016-07-31 | $-345 |
| 2016-04-30 | $-299 |
| 2016-01-31 | $-438 |
| 2015-10-31 | $-391 |
| 2015-07-31 | $-332 |
| 2015-04-30 | $-270 |
| 2015-01-31 | $-261 |
| 2014-10-31 | $-334 |
| 2014-07-31 | $53 |
| 2014-04-30 | $132 |
| 2014-01-31 | $36 |
| 2013-10-31 | $91 |
| 2013-07-31 | $-173 |
| 2013-04-30 | $-145 |
| 2013-01-31 | $-41 |
| 2012-10-31 | $-111 |
| 2012-07-31 | $-35 |
| 2012-04-30 | $68 |
| 2012-01-31 | $87 |
| 2011-10-31 | $116 |
| 2011-07-31 | $271 |
| 2011-04-30 | $278 |
| 2011-01-31 | $-63 |
| 2010-10-31 | $-88 |
| 2010-07-31 | $-225 |
| 2010-04-30 | $-239 |
| 2010-01-31 | $-201 |
| 2009-10-31 | $-185 |
| 2009-07-31 | $-141 |
| 2009-04-30 | $-188 |
| 2009-01-31 | $-154 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.187B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $218.593B | 25.64 |
| Boston Scientific (BSX) | United States | $157.132B | 37.53 |
| Stryker (SYK) | United States | $151.401B | 31.66 |
| EssilorLuxottica (ESLOY) | France | $135.007B | 0.00 |
| Medtronic (MDT) | Ireland | $118.404B | 16.78 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.975B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.249B | 25.26 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.152B | 16.69 |
| Terumo (TRUMY) | Japan | $25.999B | 33.77 |
| Koninklijke Philips (PHG) | Netherlands | $24.882B | 17.46 |
| Insulet (PODD) | United States | $20.168B | 79.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.166B | 12.31 |
| Baxter (BAX) | United States | $14.764B | 11.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.788B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.131B | 24.82 |
| Lantheus Holdings (LNTH) | United States | $4.907B | 12.38 |
| Perrigo (PRGO) | Ireland | $3.864B | 9.79 |
| Prestige Consumer Healthcare (PBH) | United States | $3.769B | 16.84 |
| Haemonetics (HAE) | United States | $3.568B | 16.25 |
| Envista Holdings (NVST) | United States | $3.503B | 29.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.180B | 23.45 |
| LeMaitre Vascular (LMAT) | United States | $1.825B | 40.79 |
| QuidelOrtho (QDEL) | United States | $1.781B | 12.25 |
| AtriCure (ATRC) | United States | $1.494B | 0.00 |
| Acuren (TIC) | United States | $1.450B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.268B | 28.52 |
| AdaptHealth (AHCO) | United States | $1.244B | 12.63 |
| Phibro Animal Health (PAHC) | United States | $1.193B | 15.25 |
| Neogen (NEOG) | United States | $1.111B | 14.22 |
| BioLife Solutions (BLFS) | United States | $1.065B | 0.00 |
| InMode (INMD) | Israel | $0.918B | 9.25 |
| Kestra Medical Technologies (KMTS) | United States | $0.871B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.851B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.707B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.690B | 0.00 |
| Valneva SE (VALN) | France | $0.646B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.09 |
| CeriBell (CBLL) | United States | $0.556B | 0.00 |
| ZimVie (ZIMV) | United States | $0.522B | 23.71 |
| Surmodics (SRDX) | United States | $0.458B | 0.00 |
| SNDL (SNDL) | Canada | $0.405B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.315B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.314B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.311B | 11.44 |
| Cresco Labs (CRLBF) | United States | $0.311B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.271B | 80.17 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 20.97 |
| OraSure Technologies (OSUR) | United States | $0.248B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| Biote (BTMD) | United States | $0.228B | 6.40 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Omeros (OMER) | United States | $0.210B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.203B | 0.00 |
| Organigram Global (OGI) | Canada | $0.202B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 15.52 |
| TriSalus Life Sciences (TLSI) | United States | $0.177B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.163B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.34 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 12.70 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Safety Shot (SHOT) | United States | $0.085B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.92 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Nephros (NEPH) | United States | $0.036B | 49.14 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |